I MAB Stock Quote IMAB - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.12

Bid

1.02

Ask

1.16

Volume

1,412,562

0.9936 Day's Range 1.20

0.00 52 Week Range 0.00

Market Cap

90.386M

Previous Close

0.9824

Open

1.05

Last Trade

1.14

Last Trade Time

Financial Volume

$ 1,572,613

VWAP

1.1133

Average Volume (3m)

Shares Outstanding

80,701,592

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

27.64M

Net Profit

-1.47B

I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will be felzartamab for the China market, a CD38 inhibitor for multiple myeloma, which we estimate will be launched in 2022. Core assets include eftansomatropin, a long-actin... I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will be felzartamab for the China market, a CD38 inhibitor for multiple myeloma, which we estimate will be launched in 2022. Core assets include eftansomatropin, a long-acting recombinant human growth hormone,or rhGH; lemzoparlimab, a potential best-in-class CD47 inhibitor; uliledlimab, a potential best-in-class CD73 inhibitor; and efineptakin alfa, a potential first-in-class long-acting IL-7 drug for tumors and treatment-associated lymphopenia. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.i-mabbiopharma.com

Headquarters

Grand Cayman, Cym

Founded

I MAB is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMAB. The last closing price for I MAB was $0.98. Over the last year, I MAB shares have traded in a share price range of $ 0.00 to $ 0.00.

I MAB currently has 80,701,592 shares outstanding. The market capitalization of I MAB is $79.28 million.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

IMAB - Frequently Asked Questions (FAQ)

What is the current I MAB share price?

The current share price of I MAB is $ 1.12

How many I MAB shares are in issue?

I MAB has 80,701,592 shares in issue

What is the market cap of I MAB?

The market capitalisation of I MAB is USD 79.28M

What is the 1 year trading range for I MAB share price?

I MAB has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the reporting currency for I MAB?

I MAB reports financial results in CNY

What is the latest annual turnover for I MAB?

The latest annual turnover of I MAB is CNY 27.64M

What is the latest annual profit for I MAB?

The latest annual profit of I MAB is CNY -1.47B

What is the registered address of I MAB?

The registered address for I MAB is PO BOX 31119, 802 WEST BAY ROAD, GRAND PAVILION, HIBISCUS WAY, GRAND CAYMAN, KY1 1205

What is the I MAB website address?

The website address for I MAB is www.i-mabbiopharma.com

Which industry sector does I MAB operate in?

I MAB operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CURRCurrenc Group Inc	$ 3.94 (183.45%)	292.68M
SANASana Biotechnology Inc	$ 4.29 (160.00%)	159.1M
ACCDAccolade Inc	$ 6.86 (104.78%)	24.84M
VIRVir Biotechnology Inc	$ 12.48 (58.17%)	39.17M
SILOSilo Pharma Inc	$ 1.71 (56.88%)	164.02M
DATSDatChat Inc	$ 3.225 (-63.89%)	10.37M
JSPRJasper Therapeutics Inc	$ 6.99 (-60.53%)	6.63M
XTIAXTI Aerospace Inc	$ 0.05 (-56.18%)	613.23M
MMVMultiMetaVerse Holdings Ltd	$ 0.50 (-48.98%)	1.57M
RGTIRigetti Computing Inc	$ 10.015 (-45.54%)	305.28M
XTIAXTI Aerospace Inc	$ 0.05 (-56.18%)	613.23M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0863 (-24.96%)	340.75M
RGTIRigetti Computing Inc	$ 10.015 (-45.54%)	305.28M
CURRCurrenc Group Inc	$ 3.94 (183.45%)	293.25M
CDTConduit Pharmaceuticals Inc	$ 0.0844 (-10.21%)	254.55M